Aug 30, 2021 4:01pm EDT Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)
Aug 19, 2021 9:35pm EDT Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering
